|
EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report
aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments
22-Aug-2024 / 18:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
aap Implantate AG ("Company") today received notification from the auditor, Baker Tilly GmbH & Co KG Wirtschaftsprüfungsgesellschaft ("Auditor"), that it will conclude the audit of the annual and consolidated financial statements on Friday, August 23, 2024, and will declare that it will not issue an audit opinion due to audit impediments. The auditor justifies this by stating that it is not in a position to complete the audit because, in its view, the necessary documents relating to the HGB individual financial statements have not been submitted in full.
The publication of the 2023 annual financial statements despite the fact that the audit has not been completed is therefore accompanied by a note of refusal. The decision to publish was made due to the threat of a six-figure penalty payment. The Executive Board is working with all available resources to resolve the audit impediment and eliminate it for the 2024 annual and consolidated financial statements.
aap Implants AG
Management Board
Contact:
aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin
Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de
End of Inside Information
22-Aug-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
aap Implantate AG |
|
Lorenzweg 5 |
|
12099 Berlin |
|
Germany |
| Phone: |
+49 (0) 30 75 019-0 |
| Fax: |
+49 (0) 30 75 019-111 |
| E-mail: |
info@aap.de |
| Internet: |
www.aap.de |
| ISIN: |
DE000A3H2101 |
| WKN: |
A3H210 |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1973467 |
| |
| End of Announcement |
EQS News Service |
1973467 22-Aug-2024 CET/CEST
EQS-Ad-hoc: aap Implantate AG / Key word(s): Annual Report
aap Implantate AG: Auditor will terminate audit and declare non-issuance of audit opinion due to audit impediments
22-Aug-2024 / 18:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
aap Implantate AG (\"Company\") today received notification from the auditor, Baker Tilly GmbH & Co KG Wirtschaftsprüfungsgesellschaft (\"Auditor\"), that it will conclude the audit of the annual and consolidated financial statements on Friday, August 23, 2024, and will declare that it will not issue an audit opinion due to audit impediments. The auditor justifies this by stating that it is not in a position to complete the audit because, in its view, the necessary documents relating to the HGB individual financial statements have not been submitted in full.
The publication of the 2023 annual financial statements despite the fact that the audit has not been completed is therefore accompanied by a note of refusal. The decision to publish was made due to the threat of a six-figure penalty payment. The Executive Board is working with all available resources to resolve the audit impediment and eliminate it for the 2024 annual and consolidated financial statements.
aap Implants AG
Management Board
Contact:
aap Implantate AG; R. Di Girolamo; Vorsitzender des Vorstands / CEO; Lorenzweg 5; D-12099 Berlin
Tel.: +49/30/750 19 – 170; Fax: +49/30/750 19 – 290; r.digirolamo@aap.de
End of Inside Information
22-Aug-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
aap Implantate AG |
| Lorenzweg 5 |
| 12099 Berlin |
| Germany |
| Phone: |
+49 (0) 30 75 019-0 |
| Fax: |
+49 (0) 30 75 019-111 |
| E-mail: |
info@aap.de |
| Internet: |
www.aap.de |
| ISIN: |
DE000A3H2101 |
| WKN: |
A3H210 |
| Listed: |
Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: |
1973467 |
| |
| End of Announcement |
EQS News Service |
1973467 22-Aug-2024 CET/CEST
![\"fncls.ssp?fn=show_t_gif&application_id=1973467&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6\"](\"https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1973467&application_name=news&site_id=symex~~~af100301-a623-4c64-8f3d-90fc88eca9e6\")
|